BridgeMD
New treatment option for Hemiparetic Cerebral Palsy
Official title Using Neurotechology to Help Children With Physical Disability Due to Cerebral Palsy
ClinicalTrials.gov ID: NCT07269353
What this study is testing
- What it's testing
- Hemiparetic cerebral palsy is a condition in which one side of a child's body becomes weak due to brain injury occurring around birth, often caused by stroke. Weakness on the affected side reduces the ability to use the involved hand and arm, limiting everyday activities such as dressing, eating, and playing.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17
You may be able to join if
- Clinically confirmed and functionally disabling moderate to severe hemiparetic CP (GMFCS levels I-IV and MACS levels II\&III) with personalized goals...
- Age 12-17 years,
- Informed Consent/assent,
- Normal corrected vision and hearing
- Ability to maintain supported sitting for 30 min or more
You likely can't join if
- Bilateral perinatal stroke
- Motor strength of wrist extension zero
- Severe hemiparesis (MACS V)
- Severe developmental delay and/or other inability to comply with study protocol
- Severe wrist contractures limiting wrist extension
- Upper extremity orthopedic surgery or botulinum toxin in the preceding 6 months,
See the full eligibility criteria
- Clinically confirmed and functionally disabling moderate to severe hemiparetic CP (GMFCS levels I-IV and MACS levels II\&III) with personalized goals that include improvement of wrist extension of affected upper...
- Age 12-17 years,
- Informed Consent/assent,
- Normal corrected vision and hearing
- Ability to maintain supported sitting for 30 min or more
- Bilateral perinatal stroke
- Motor strength of wrist extension zero
- Severe hemiparesis (MACS V)
- Severe developmental delay and/or other inability to comply with study protocol
- Severe wrist contractures limiting wrist extension
- Upper extremity orthopedic surgery or botulinum toxin in the preceding 6 months,
- Initial classification accuracy below level of significance (as determined by the BCI system)
The study team makes the final eligibility decision.
Where it's taking place
- Edmonton, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edmonton, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.